Staff

Sunsetting of the Vanier and Banting programs

yang.chen6@mcgill.ca — Mon, 10 Feb 2025 16:22:45 +0000

In alignment with the Tri-Agency Research Training Strategy and as announced in Budget 2024, the three federal granting agencies, the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering and Research Council (NSERC), and the Social Sciences and Humanities Research Council (SSHRC) are working to offer a harmonized and streaml

Banting Application 2024 Internal Review Deadline _FMHS

yang.chen6@mcgill.ca — Thu, 11 Apr 2024 13:47:05 +0000

An open solution to improving research reproducibility

admin — Wed, 18 Dec 2024 16:12:19 +0000

Academic and industry scientists collaborate on a new method to characterize research antibodies

Six principal investigators from The Neuro receive CIHR grants

admin — Mon, 10 Feb 2025 18:44:57 +0000

Projects include important research on Parkinson’s, glioblastoma and dementia

Expanding access to specialized healthcare across Quebec: ECHO Superhub at The Neuro

admin — Tue, 25 Mar 2025 18:37:02 +0000

Free, online training program strengthens training and brings specialized care to communities across Quebec

A healthcare telementoring program housed at The Neuro and supported by the Transforming Autism Care Consortium (TACC) is expanding its reach after achieving designation as an ECHO Superhub. Under the direction of Julie Scorah, PhD, this milestone ensures that specialized knowledge reaches underserved communities.

At-home neurological disorder diagnosis project receives major funding

admin — Fri, 08 Nov 2024 18:24:33 +0000

$1M grant from The Weston Family Foundation will pave the way for earlier intervention in REM sleep behaviour disorder and Parkinson’s disease

REM sleep behaviour disorder (RBD) is an often debilitating condition that causes people to act out in their sleep, sometimes violently. What’s worse, people with the disorder often go on to develop Parkinson’s disease.

Project to create AI model for ALS receives Génome Québec funding

admin — Mon, 17 Mar 2025 15:29:17 +0000

$400,000 will fuel public-private collaboration to discover new disease biomarkers

A new project co-led by Thomas Durcan, PhD, Director of The Neuro's Early Drug Discovery Unit, and overseen by Mathilde Chaineau, PhD, the EDDU’s program manager, will receive $400,000 in support from Génome Québec. In partnership with Nardin Nakhla and Armstrong Murira from the Montreal-based company Simmunome, Durcan and Chaineau will develop a computational model of amyotrophic lateral sclerosis (ALS) on which to test for new biomarkers and therapeutic targets.

Prescribing anti-swelling drug reduces immune response weeks after last dose

admin — Wed, 26 Feb 2025 16:05:58 +0000

Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy

Swelling caused by brain cancer is a problem that can lead to serious side effects and even death. While controlling swelling is important, a new study shows that a commonly prescribed anti-swelling drug suppresses the immune system for weeks after dosage, inhibiting the body’s ability to fight the cancer.

Open Science project funded for $1.5M

admin — Tue, 12 Nov 2024 16:51:24 +0000

YCharOS antibody characterization platform addresses the “reproducibility crisis” in research

An innovative research project led by researchers at The Neuro has been awarded $1.5M by the Government of Quebec through CQDM.

YCharOS is an innovative platform led by neuroscientists Peter McPherson and Carl Laflamme that validates antibody reagents for human proteins.

D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer

admin — Wed, 26 Mar 2025 11:03:15 +0000

Montreal, March 26, 2025 – 91��’s DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on March 13, 2025.

AI analysis of healthcare records reveals key factors in autism diagnosis

admin — Wed, 26 Mar 2025 15:23:21 +0000

Scientists argue the criteria we use for diagnosing autism may need revision

Without clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

Genetic sequencing project receives more than $8 million in funding

admin — Tue, 18 Mar 2025 14:55:14 +0000

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians

A project led by Ziv Gan-Or, MD, PhD, at The Neuro (Montreal Neurological Institute-Hospital) of 91�� and Martine Tétreault, PhD, at Université de Montréal has received more than $8 million to sequence the genomes of 8,700 people, to map the role of genetics in neurological disorders.

Caring Conversations - Home care or care home?

admin — Thu, 31 Oct 2024 18:51:13 +0000

Caring Conversations is an online forum for care partners of people living with dementia to learn from experts, share concerns and ask questions.

FREE Hearing Screening

admin — Mon, 04 Nov 2024 17:30:07 +0000

No apppointment needed.

First come, first serve.

Thank you

Fourteen 91��ians appointed to the Order of Canada

admin — Wed, 18 Dec 2024 23:15:11 +0000

Governor General recognizes 91�� community members for exceptional accomplishments and service

Fourteen members of the 91�� community have been appointed to the Order of Canada, one of the country’s highest civilian honours.

Among the honourees are the University’s Chancellor and three professors: